[Bright light therapy in schizophrenic diseases].
20 patients with schizophrenic disorders, displaying a depressive syndrome, were given bright-light therapy, and compared with 11 patients treated by means of partial deprivation of sleep. Against a figure of 27% in the case of sleep-deprivation, syndrome remittance was 55% in the case of bright-light therapy. Psychometric data were obtained by use of three external-assessment schemes (HAMD, BPRS, and NOSIE) and two self-assessment procedures (TSD, POMS). As depressive syndromes improve under bright-light therapy, schizophrenic symptoms also recede, which suggests close syndromatologic links in the sense of a universal genesis of psychoses.
Heim
M
M
Klinik für Frauenpsychiatrie, Bezirkskrankenhauses für Neurologie und Psychiatrie Arnsdorf bei Dresden.
D000928:Antidepressive Agents / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000627:therapeutic use; D003131:Combined Modality Therapy; D003866:Depressive Disorder / Q000523:psychology / Q000628:therapy*; D005500:Follow-Up Studies; D006801:Humans; D010789:Phototherapy / Q000379:methods*; D011569:Psychiatric Status Rating Scales; D012559:Schizophrenia / Q000628:therapy*; D012565:Schizophrenic Psychology; D012892:Sleep Deprivation
D000928:Antidepressive Agents; D014150:Antipsychotic Agents
Bright-Light-Therapie bei schizophrenen Erkrankungen.